Skip to content

Research at St Andrews

Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality

Research output: Contribution to journalArticle

Author(s)

B. Makubate, P.T. Donnan, J.A. Dewar, A.M. Thompson, C. Mccowan

School/Research organisations

Abstract

Background: Adjuvant endocrine therapy is recommended for women with oestrogen receptor-positive breast cancer, but many women do not take the medication as directed and they stop treatment before completing the standard 5-year duration.

Methods: This retrospective cohort study conducted between 1993 and 2008 of all women with incident breast cancer, who are residing in the Tayside region of Scotland, examined adherence to prescribed adjuvant tamoxifen or aromatase inhibitors (AIs). Survival analysis examined the effect of adherence on all-cause mortality, breast cancer death and recurrence, using linked prescribing, cancer registry, clinical cancer audit, hospital discharge and death records.

Results: A total of 3361 women with breast cancer were followed for a median 4.47 years (interquartile range (IQR)=2.04?8.55). The median overall adherence was 90% (IQR=90?100, but the annual adherence reduced after a longer period from diagnosis. Low adherence of 60;80% was associated with poorer survival (hazard ratios=1.20; 95% confidence interval=1.03?1.40, P=0.019). There was no significant difference for low adherence over the treatment period and recurrence, or breast cancer death, but patients with high annual adherence for 5 years had better outcomes than those with 3 or less.

Conclusion: Low adherence to all adjuvant endocrine therapy for women with breast cancer, whether tamoxifen or AI, increases the risk of death.

Close

Details

Original languageUndefined/Unknown
Pages (from-to)1515-1524
Number of pages10
JournalBritish Journal of Cancer
Volume108
Issue number7
DOIs
Publication statusPublished - 1 Apr 2013

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors

    Mark, P. B., Papworth, R., Ramparsad, N., Tomlinson, L. A., Sahwney, S., Black, C., McConnachie, A. & McCowan, C., 25 Sep 2019, (Accepted/In press) In : British Journal of Clinical Pharmacology.

    Research output: Contribution to journalArticle

  2. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study

    McCowan, C., McSkimming, P., Papworth, R., Kotzur, M., McConnachie, A., Macdonald, S., Wyke, S., Crighton, E., Campbell, C., Weller, D., Steele, R. JC. & Robb, K. A., 4 Sep 2019, In : British Journal of Cancer. 5 p.

    Research output: Contribution to journalArticle

  3. Healthcare disparities for women hospitalised with myocardial infarction and angina

    Jackson, A. M., Zhang, R., Robertson, K., Lindsay, M., Morris, T., Forbes, B., Papworth, R., McConnachie, A., Mangion, K., Jhund, P. S., McCowan, C. & Berry, C., 25 Jul 2019, In : European Heart Journal - Quality of Care and Clinical Outcomes.

    Research output: Contribution to journalArticle

  4. Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study

    Gray, C. M., Wyke, S., Zhang, R., Anderson, A. S., Barry, S., Brennan, G., Briggs, A., Boyer, N., Bunn, C., Donnachie, C., Grieve, E., Kohli-Lynch, C., Lloyd, S., McConnachie, A., McCowan, C., McLean, A., Mutrie, N. & Hunt, K., 1 Jul 2018, In : Public Health Research. 6, 9

    Research output: Contribution to journalArticle

  5. Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in National Health Service Scotland

    Findlay, I., Morris, T., Zhang, R., McCowan, C., Shield, S., Forbes, B., McConnachie, A., Mangion, K. & Berry, C., Jul 2018, In : European Heart Journal - Quality of Care and Clinical Outcomes. 4, 3, p. 155-167

    Research output: Contribution to journalArticle

Related by journal

  1. Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study

    McCowan, C., McSkimming, P., Papworth, R., Kotzur, M., McConnachie, A., Macdonald, S., Wyke, S., Crighton, E., Campbell, C., Weller, D., Steele, R. JC. & Robb, K. A., 4 Sep 2019, In : British Journal of Cancer. 5 p.

    Research output: Contribution to journalArticle

  2. Antitumour activity of the novel flavonoid oncamex in preclinical breast cancer models

    Martínez-Pérez, C., Ward, C., Turnbull, A. K., Mullen, P., Cook, G., Meehan, J., Jarman, E. J., Thomson, P. I. T., Campbell, C. J., McPhail, D., Harrison, D. J. & Langdon, S. P., 13 Apr 2016, In : British Journal of Cancer. 114, 8, p. 905-916

    Research output: Contribution to journalArticle

  3. Aspirin use and survival after the diagnosis of breast cancer: A population-based cohort study

    Fraser, D. M., Sullivan, F. M., Thompson, A. M. & McCowan, C., 29 Jul 2014, In : British Journal of Cancer. 111, 3, p. 623-627 5 p.

    Research output: Contribution to journalArticle

  4. Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer

    Koussounadis, A., Langdon, S. P., Harrison, D. J. & Smith, V. A., 10 Jun 2014, In : British Journal of Cancer. 110, 12, p. 2975-2984 10 p.

    Research output: Contribution to journalArticle

ID: 257574442

Top